Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Compugen Announces First Milestone In License Deal With AstraZeneca On Bispecific, Multi-specific Antibody Products


RTTNews | Dec 23, 2020 07:03AM EST

07:03 Wednesday, December 23, 2020 (RTTNews) - Compugen Announces First Milestone In License Deal With AstraZeneca On Bispecific, Multi-specific Antibody Products

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC